Insider Transactions in Q1 2023 at Cara Therapeutics, Inc. (CARA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2023
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,221
-9.56%
|
$55,989
$9.71 P/Share
|
|
Mar 03
2023
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
6,256
-6.27%
|
$56,304
$9.71 P/Share
|
|
Mar 03
2023
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
SELL
Open market or private sale
|
Direct |
6,802
-4.09%
|
$61,218
$9.71 P/Share
|
|
Mar 03
2023
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
5,987
-3.28%
|
$53,883
$9.71 P/Share
|
|
Feb 16
2023
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,265
-3.36%
|
$22,650
$10.2 P/Share
|
|
Feb 08
2023
|
Ryan D Maynard CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,488
-40.65%
|
$0
$0.53 P/Share
|
|
Feb 08
2023
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
7,770
-7.61%
|
$0
$0.53 P/Share
|
|
Feb 08
2023
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,770
-11.57%
|
$0
$0.53 P/Share
|
|
Feb 02
2023
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
4,191
-2.25%
|
$46,101
$11.8 P/Share
|
|
Jan 17
2023
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,265
-3.25%
|
$22,650
$10.81 P/Share
|